Medical News

RSS

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Interventional radiologists-minimally invasive specialists-will share scientific advances and new discoveries in treating a host of diseases at the Society of Interventional Radiology's 35th Annual Scientific Meeting March 13󈝾 at the Tampa Convention Center, Tampa, Fla. This year's meeting theme is "IR Innovation"-one that celebrates the remarkable inventiveness of interventional radiologists.

25 Feb 2010

Consumer Watchdog: Insurers’ finances should be examined for unjustified profit transfers and suspect contracting

The House subcommittee grilling Blue Cross chief executive Angela Braly today should expand its financial examination of Blue Cross and its parent, WellPoint, to include billions of dollars in dividend transfers and no-bid "service contracts" with affiliate companies, said Consumer Watchdog.

25 Feb 2010

Stereotaxis' revenue for recent fourth-quarter increases 16%

Stereotaxis, Inc. today reported its financial results for the quarter and the year ended December 31, 2009. Revenue for the recent fourth quarter grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago.

25 Feb 2010

CHOP and AIAM collaborate to develop more accurate child crash test dummies

A research report released today by The Children's Hospital of Philadelphia (CHOP) and the Association of International Automobile Manufacturers, Inc. (AIAM) details CHOP's cutting-edge work with academic and industry collaborators to develop more accurate child crash test dummies, called child anthropometric test devices (ATD's).

25 Feb 2010

IOS Press announces the 20th anniversary of Restorative Neurology and Neuroscience journal

IOS Press is pleased to announce the 20th anniversary of the peer-reviewed journal Restorative Neurology and Neuroscience. Since founded in 1989 by pioneering neuroscientist Donald G. Stein, RNN has focused on the emerging field of brain plasticity, repair and rehabilitation and has published not only numerous original scientific publications, but also review papers in basic research (animal experiments, in vitro studies) and in the clinical sciences.

25 Feb 2010

Cannabis Science completes selection of initial cannabis-based pharmaceutical for FDA clinical trials

Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company’s FDA filings.

25 Feb 2010

Healthcare industries pay millions to summit invitees, says CREW’s study

On the eve of President Obama’s health care reform summit, Citizens for Responsibility and Ethics in Washington (CREW) released data showing that since 2005, health care special interests have invested at least $28 million in the campaigns of House and Senate leaders, chairs and ranking members of committees with primary jurisdiction over health care legislation. Additionally, President Obama received over $18.6 million during his presidential campaign.

25 Feb 2010

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.

25 Feb 2010

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.

25 Feb 2010

The Coalition for Evidence-Based Policy selects Botvin LST as "Top Tier" program

Botvin LifeSkills Training has been selected as a "Top Tier" program by The Coalition for Evidence-Based Policy. The Top Tier initiative, which is being followed closely by Congress, focuses on identifying and validating social programs meeting the highest standard of evidence of effectiveness.

25 Feb 2010

Study demonstrates Prochymal treamtent is safe for cardiac patients

“Patients receiving Prochymal did better than those receiving only standard-of-care,” said Dr. Hare, lead author of the JACC publication.

25 Feb 2010

Little Company of Mary installs Toshiba America Medical Systems' Vantage Atlas MR system

In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish this, the facility installed Toshiba America Medical Systems, Inc.’s Vantage Atlas® MR system and utilized the full suite of proprietary contrast-free MRA techniques.

25 Feb 2010

ICON reports net revenues of $227.4M for fourth-quarter 2009

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2009.

25 Feb 2010

Caliper Life Sciences files patent infringement lawsuit against Carestream Health

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, and its wholly owned subsidiary Xenogen Corporation, today announced the filing of a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas.

25 Feb 2010

FEHBP's H.R. 4489 overhaul will undermine cost-saving tools and disrupt prescription drug benefits

“Regrettably, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (H.R. 4489) would undermine many of the cost-saving tools used in FEHBP and disrupt prescription drug benefits for 8 million federal employees, retirees, and their families.”

25 Feb 2010

Translational Regenerative Medicine Forum in Winston-Salem

A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem.

25 Feb 2010

Delays and variability in UK clinical research projects result in skill shortages

Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.

25 Feb 2010

Semafore Pharmaceuticals awarded U.S. patent covering PI-3 kinase inhibitor prodrugs

Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled “PI-3 Kinase Inhibitor Prodrugs.” This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore’s clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.

25 Feb 2010

Revised model will help scientists in understanding transport of fluid constituents

Combined mechanisms of transport have important applications-transport of nutrients across cell membranes in plants and animals, the aeration of agricultural soils, performance of chemical reactors, the design of membranes for desalting brackish water, and the design of clay membranes for retaining dangerous chemicals. Because mass transport of fluid constituents has important roles in biology, physics, and chemistry, one would assume that such transport would be well understood by the scientific community.

25 Feb 2010

Pew's report highlights need for effective oral health delivery system

"We welcome the Pew organization to our longstanding fight to improve the lives of American children by helping more of them enjoy the good oral health that too many of them now lack.

25 Feb 2010

Medical News

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Consumer Watchdog: Insurers’ finances should be examined for unjustified profit transfers and suspect contracting

Stereotaxis' revenue for recent fourth-quarter increases 16%

CHOP and AIAM collaborate to develop more accurate child crash test dummies

IOS Press announces the 20th anniversary of Restorative Neurology and Neuroscience journal

Cannabis Science completes selection of initial cannabis-based pharmaceutical for FDA clinical trials

Healthcare industries pay millions to summit invitees, says CREW’s study

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

The Coalition for Evidence-Based Policy selects Botvin LST as "Top Tier" program

Study demonstrates Prochymal treamtent is safe for cardiac patients

Little Company of Mary installs Toshiba America Medical Systems' Vantage Atlas MR system

ICON reports net revenues of $227.4M for fourth-quarter 2009

Caliper Life Sciences files patent infringement lawsuit against Carestream Health

FEHBP's H.R. 4489 overhaul will undermine cost-saving tools and disrupt prescription drug benefits

Translational Regenerative Medicine Forum in Winston-Salem

Delays and variability in UK clinical research projects result in skill shortages

Semafore Pharmaceuticals awarded U.S. patent covering PI-3 kinase inhibitor prodrugs

Revised model will help scientists in understanding transport of fluid constituents

Pew's report highlights need for effective oral health delivery system

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News